US Stock MarketDetailed Quotes

BEAM Beam Therapeutics

Watchlist

29.840
-0.950-3.09%

Close Feb 25 16:00 ET

29.160
-0.680-2.28%

Post 20:01 ET

2.47BMarket Cap-18.89P/E (TTM)

Beam Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Beam Therapeutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 3 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual

Estimate

Date	Period	Revenue/Estimate	Earnings Call
--	2025/Q2	-- / 15.639M	--
--	2025/Q1	-- / 15.589M	--
--	2024/Q4	30.067M / 16.474M	--
Nov 5, 2024	2024/Q3	14.269M / 14.132M	--
--	2024/Q2	11.772M / 13.047M	--

DatePeriodRevenue/EstimateEarnings Call

--2025/Q2-- / 15.639M--

--2025/Q1-- / 15.589M--

--2024/Q430.067M / 16.474M--

Nov 5, 20242024/Q314.269M / 14.132M--

--2024/Q211.772M / 13.047M--

Unlock Free Earnings Estimates

Open Account

Beam Therapeutics Earnings Reports

Beam Therapeutics | 10-K: FY2024 Annual Report

Feb 25 07:31 ET

Beam Therapeutics | 8-K: Beam Therapeutics Reports Fourth Quarter and Year-End 2024 Financial Results and Reiterates Anticipated Catalysts

Feb 25 07:21 ET

Beam Therapeutics | 10-Q: Q3 2024 Earnings Report

Nov 5, 2024 09:11 ET

Beam Therapeutics | 8-K: Beam Therapeutics Reports Third Quarter 2024 Financial Results and Progress Across Priority Programs

Nov 5, 2024 07:06 ET